City
Epaper

More US states offering boosters amid fear of winter surge

By IANS | Updated: November 18, 2021 08:45 IST

Washington, Nov 18 Amid fear of a Covid-19 resurgence in the upcoming winter season, more states in the ...

Open in App

Washington, Nov 18 Amid fear of a Covid-19 resurgence in the upcoming winter season, more states in the US have started offering booster doses, according to reports.

California made the first move to expand access when public health officials quietly sent a letter to local health jurisdictions and vaccine providers on November 9 instructing them to trust patients to decide whether a booster is appropriate, Xinhua news agency reported on Thursday.

Within days, officials in Colorado, New Mexico, Arkansas, West Virginia and New York City endorsed boosters for all adults.

"More states and jurisdictions are expected to follow," The Washington Post said in a report on Tuesday.

"If you're in doubt and you meet the waiting period, just get a booster. Choose the side of greater protection," Democratic New Jersey Governor Phil Murphy was quoted as saying on Monday.

"With the holidays coming up, we need as many people boosted as possible. It's that simple."

The Food and Drug Administration (FDA) is aiming to authorise booster doses of Pfizer-BioNTech's coronavirus vaccine for all adults as early as Thursday.

A report in The New York Times said that the "move that would expand the number of Americans eligible for additional shots by tens of millions".

The Centers for Disease Control and Prevention's (CDC) independent committee of vaccine experts has scheduled a meeting for Friday to discuss data on the booster dose's efficacy and safety.

If both the FDA and the CDC sign off this week, they will have acted strikingly quickly, a little more than a week after Pfizer asked for authorization of boosters for everyone 18 and older.

Under that scenario, any adult who received a second dose of the vaccine at least six months earlier would be officially eligible to get a booster as soon as this weekend.

The FDA is reportedly expected to rule without consulting its own expert panel, which has met frequently during the pandemic to review vaccine data and make a recommendation ahead of a regulatory decision.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: usXinhuaNew York CityPhil MurphyThe Washington PostPost facebookAmazon washington post
Open in App

Related Stories

BusinessGlobal Tech Firms Eye India for Manufacturing Amid US-China Tensions

InternationalIllinois Plane Crash: 4 Killed After Cessna C180G Aircraft Goes Down After Hitting Power Lines in Trilla

NationalPM Narendra Modi Discusses Tech and Innovation Collaboration With Elon Musk

InternationalCalifornia Shooting: 6 People Injured in Firing Outside Barbershop in Stockton

InternationalNYC Helicopter Crash: Siemens CEO Agustin Escobar, Wife and Three Children Killed in Hudson River Crash

Health Realted Stories

HealthCentre to unveil digital portal for medical value travel: Minister

HealthPilot plant of fortified rice kernels launched at CSIR-NIIST

HealthEven light exercise can help slow cognitive decline in people at risk of Alzheimer's: Study

HealthCountrymen collectively, strongly fought malaria: PM Modi

HealthKerala Health Minister seeks report on why she was not invited to cathlab inauguration